Inhibidores de la neuraminidasa covalentes basados en el mecanismo con un amplio espectro de actividad antiviral de la influenza
Video Experimental Relacionado
Updated: May 14, 2026
09:31
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Jin-Hyo Kim1, Ricardo Resende, Tom Wennekes
1Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada.
Science (New York, N.Y.)
|February 23, 2013
Resumen
Se ha desarrollado una nueva clase de antivirales contra la influenza, dirigidos a la enzima neuraminidasa. Estos medicamentos basados en el mecanismo muestran una eficacia comparable a los tratamientos existentes y actividad contra las cepas resistentes.
Área de la Ciencia:
- Virología y descubrimiento de fármacos.
- Bioquímica y Biología Molecular.
Sus antecedentes:
- Los agentes antivirales de la gripe son cruciales para controlar la gravedad de la enfermedad y las pandemias.
- La resistencia emergente a los inhibidores de la neuraminidasa como el oseltamivir requiere nuevas estrategias terapéuticas.
- El desarrollo de nuevos candidatos antivirales es esencial para el control sostenido de la influenza.
Objetivo del estudio:
- Introducir una nueva clase de fármacos contra la gripe específicos basados en el mecanismo.
- Para dilucidar el modo de acción que implica un intermediario covalente estabilizado en la enzima neuraminidasa de la influenza.
- Evaluar la eficacia y el espectro de actividad de estos nuevos compuestos.
Principales métodos:
- Estudios estructurales y mecanicistas para confirmar el modo de acción del fármaco.
- Pruebas basadas en células para evaluar la actividad antiviral.
- Modelos animales para evaluar la eficacia in vivo.
- Pruebas in vitro contra las cepas de gripe resistentes a los medicamentos.
Principales resultados:
- Se identificó una nueva clase de medicamentos contra la gripe, que funcionan a través de un intermediario covalente estabilizado.
- Los compuestos demostraron una eficacia comparable al inhibidor de la neuraminidasa zanamivir en modelos celulares y animales.
- Se observó actividad de amplio espectro contra cepas de influenza resistentes a los medicamentos in vitro.
Conclusiones:
- Los nuevos fármacos basados en el mecanismo representan candidatos prometedores para la terapia antiviral de la influenza.
- Su similitud estructural con el sustrato natural y su mecanismo único mejoran su potencial terapéutico.
- Estos agentes ofrecen una alternativa viable contra las cepas de gripe resistentes.
Videos de Conceptos Relacionados
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...